335 related articles for article (PubMed ID: 16379339)
1. Influence of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, B vitamins and other factors on plasma homocysteine and risk of thromboembolic disease in Chinese.
Ho CH; Kuo BI; Kong CW; Chau WK; Hsu HC; Gau JP; Yu YB
J Chin Med Assoc; 2005 Dec; 68(12):560-5. PubMed ID: 16379339
[TBL] [Abstract][Full Text] [Related]
2. The influence of age, sex, vitamin B(12), folate levels and methylenetetrahydrofolate reductase C677T genetic mutations on plasma homocysteine in the Chinese population.
Ho CH
Haematologica; 2000 Oct; 85(10):1051-4. PubMed ID: 11025596
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: a facet of nature-nurture interplay.
Herrmann W; Obeid R; Schorr H; Zarzour W; Geisel J
Clin Chem Lab Med; 2003 Apr; 41(4):547-53. PubMed ID: 12747601
[TBL] [Abstract][Full Text] [Related]
4. Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians.
Gupta SK; Kotwal J; Kotwal A; Dhall A; Garg S
Indian J Med Res; 2012 Apr; 135(4):506-12. PubMed ID: 22664498
[TBL] [Abstract][Full Text] [Related]
5. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
[TBL] [Abstract][Full Text] [Related]
6. Association between the MTHFR C677T polymorphism, blood folate and vitamin B12 deficiency, and elevated serum total homocysteine in healthy individuals in Yunnan Province, China.
Ni J; Zhang L; Zhou T; Xu WJ; Xue JL; Cao N; Wang X
J Chin Med Assoc; 2017 Mar; 80(3):147-153. PubMed ID: 28094233
[TBL] [Abstract][Full Text] [Related]
7. Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients.
Biselli PM; Sanches de Alvarenga MP; Abbud-Filho M; Ferreira-Baptista MA; Galbiatti AL; Goto MT; Cardoso MA; Eberlin MN; Haddad R; Goloni-Bertollo EM; Pavarino-Bertelli EC
Transplant Proc; 2007 Dec; 39(10):3163-5. PubMed ID: 18089344
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.
Andreassi MG; Botto N; Cocci F; Battaglia D; Antonioli E; Masetti S; Manfredi S; Colombo MG; Biagini A; Clerico A
Hum Genet; 2003 Feb; 112(2):171-7. PubMed ID: 12522558
[TBL] [Abstract][Full Text] [Related]
9. Plasma Homocysteine, Serum Folic Acid, Serum Vitamin B12, Serum Vitamin B6, MTHFR, and Risk of Normal-Tension Glaucoma.
Li J; Xu F; Zeng R; Gong H; Lan Y
J Glaucoma; 2016 Feb; 25(2):e94-8. PubMed ID: 26171850
[TBL] [Abstract][Full Text] [Related]
10. Effects of the interaction between the C677T 5,10-methylenetetrahydrofolate reductase polymorphism and serum B vitamins on homocysteine levels in pregnant women.
Kim KN; Kim YJ; Chang N
Eur J Clin Nutr; 2004 Jan; 58(1):10-6. PubMed ID: 14679361
[TBL] [Abstract][Full Text] [Related]
11. Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
Huh HJ; Chi HS; Shim EH; Jang S; Park CJ
Thromb Res; 2006; 117(5):501-6. PubMed ID: 15935452
[TBL] [Abstract][Full Text] [Related]
12. Folate, vitamin B12 and Homocysteine status in the post-folic acid fortification era in different subgroups of the Brazilian population attended to at a public health care center.
Barnabé A; Aléssio AC; Bittar LF; de Moraes Mazetto B; Bicudo AM; de Paula EV; Höehr NF; Annichino-Bizzacchi JM
Nutr J; 2015 Feb; 14():19. PubMed ID: 25886278
[TBL] [Abstract][Full Text] [Related]
13. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
[TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase gene polymorphism in Indian stroke patients.
Kalita J; Srivastava R; Bansal V; Agarwal S; Misra UK
Neurol India; 2006 Sep; 54(3):260-3. PubMed ID: 16936384
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease.
Kölling K; Ndrepepa G; Koch W; Braun S; Mehilli J; Schömig A; Kastrati A
Am J Cardiol; 2004 May; 93(10):1201-6. PubMed ID: 15135689
[TBL] [Abstract][Full Text] [Related]
16. Plasma homocysteine, serum folic acid, serum vitamin B12, serum vitamin B6, MTHFR and risk of pseudoexfoliation glaucoma: a meta-analysis.
Xu F; Zhang L; Li M
Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):1067-74. PubMed ID: 22134713
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
18. Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin.
Russo GT; Giandalia A; Romeo EL; Scarcella C; Gambadoro N; Zingale R; Forte F; Perdichizzi G; Alibrandi A; Cucinotta D
J Endocrinol Invest; 2016 Mar; 39(3):305-14. PubMed ID: 26233336
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
[TBL] [Abstract][Full Text] [Related]
20. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
